This study is for people with HIGH BLOOD PRESSURE who are not responding to treatment with three or more medications.
The study is investigating a drug that aims to reduce the amount of protein called angiotensinogen. The hope is that by blocking this protein, blood pressure levels will lower. The study drug is administered by subcutaneous injection once a week.
Study participants will receive compensation for time and travel.